Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

New Zealand (NZX) Pharma Industry Analysis

UpdatedJun 27, 2026
DataAggregated Company Financials
Companies3
  • 7D1.0%
  • 3M7.7%
  • 1Y33.6%
  • YTD7.9%

In the last week, the Pharma industry is flat overall, with Rua Bioscience standing out by going down 3.3%. As for the the longer term, the industry is up 34% over the past 12 months. Looking forward, earnings are forecast to grow by 18% annually.

Industry Valuation and Performance

Has the New Zealand Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 27 Jun 2026NZ$416.2mNZ$271.8mNZ$12.0m27.9x34.8x1.5x
Mon, 25 May 2026NZ$435.5mNZ$272.1mNZ$12.0m27.7x36.4x1.6x
Wed, 22 Apr 2026NZ$406.4mNZ$253.0mNZ$15.0m20.7x27x1.6x
Fri, 20 Mar 2026NZ$397.4mNZ$253.0mNZ$15.0m19.9x26.4x1.6x
Sun, 15 Feb 2026NZ$421.6mNZ$252.4mNZ$15.0m21.7x28.1x1.7x
Tue, 13 Jan 2026NZ$403.8mNZ$252.4mNZ$15.0m21.2x26.9x1.6x
Thu, 11 Dec 2025NZ$406.3mNZ$252.4mNZ$15.0m21.4x27.1x1.6x
Sat, 08 Nov 2025NZ$373.1mNZ$222.5mNZ$9.3m26x39.9x1.7x
Mon, 06 Oct 2025NZ$323.1mNZ$222.5mNZ$9.3m24.4x34.6x1.5x
Wed, 03 Sep 2025NZ$328.4mNZ$222.6mNZ$9.3m26x35.1x1.5x
Fri, 01 Aug 2025NZ$314.4mNZ$221.8mNZ$8.1m24.8x38.7x1.4x
Sun, 29 Jun 2025NZ$308.4mNZ$221.8mNZ$8.1m23.3x37.9x1.4x
Tue, 27 May 2025NZ$318.3mNZ$222.2mNZ$8.1m24.4x39.1x1.4x
Thu, 24 Apr 2025NZ$296.2mNZ$212.4mNZ$8.5m17.5x34.9x1.4x
Sat, 22 Mar 2025NZ$299.0mNZ$212.4mNZ$8.5m17.6x35.2x1.4x
Mon, 17 Feb 2025NZ$313.6mNZ$211.6m-NZ$566,754.0018.5x-553.4x1.5x
Wed, 15 Jan 2025NZ$340.3mNZ$211.6m-NZ$566,754.0020x-600.4x1.6x
Fri, 13 Dec 2024NZ$325.4mNZ$211.6m-NZ$566,754.0019.1x-574.1x1.5x
Sun, 10 Nov 2024NZ$310.8mNZ$207.3mNZ$2.5m26.8x122.5x1.5x
Tue, 08 Oct 2024NZ$341.5mNZ$207.3mNZ$2.5m22.9x134.6x1.6x
Thu, 05 Sep 2024NZ$389.7mNZ$207.3mNZ$2.5m31.2x153.7x1.9x
Sat, 03 Aug 2024NZ$360.9mNZ$207.5m-NZ$1,274,813.0026.4x-283.1x1.7x
Mon, 01 Jul 2024NZ$351.2mNZ$207.5m-NZ$1,274,813.0027.1x-275.5x1.7x
Wed, 29 May 2024NZ$391.5mNZ$208.9m-NZ$10,082,906.0026.7x-38.8x1.9x
Fri, 26 Apr 2024NZ$390.9mNZ$186.8m-NZ$15,744,906.0029.5x-24.8x2.1x
Sun, 24 Mar 2024NZ$376.1mNZ$186.8m-NZ$15,744,906.0028.3x-23.9x2x
Tue, 20 Feb 2024NZ$447.1mNZ$185.9mNZ$4.6m33.5x96.5x2.4x
Thu, 18 Jan 2024NZ$479.4mNZ$185.9mNZ$4.6m36.1x103.5x2.6x
Sat, 16 Dec 2023NZ$446.5mNZ$185.9mNZ$4.6m32.4x96.3x2.4x
Mon, 13 Nov 2023NZ$454.1mNZ$167.6mNZ$3.3m32.6x135.8x2.7x
Wed, 11 Oct 2023NZ$467.8mNZ$167.6mNZ$3.3m33.2x139.9x2.8x
Fri, 08 Sep 2023NZ$547.8mNZ$173.6m-NZ$4,579,906.0034.1x-119.6x3.2x
Sun, 06 Aug 2023NZ$499.6mNZ$167.6m-NZ$4,073,109.0034.8x-122.6x3x
Tue, 04 Jul 2023NZ$523.5mNZ$167.6m-NZ$4,073,109.0035.2x-128.5x3.1x
Price to Earnings Ratio

-128.5x


Total Market Cap: NZ$523.5mTotal Earnings: -NZ$4,073,109.00Total Revenue: NZ$167.6mTotal Market Cap vs Earnings and Revenue0%0%0%
New Zealand Pharma Industry Price to Earnings3Y Average -35.7x202420252026
Current Industry PE
    There are only 3 companies in the New Zealander Pharmaceuticals industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • Total earnings for the Pharmaceuticals industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 17% per year.
  • This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.

Industry Trends

Which industries have driven the changes within the New Zealand Healthcare industry?

NZ Market-0.63%
Healthcare0.18%
Pharma0.99%
Pharma0.99%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
AFT AFT PharmaceuticalsNZ$3.680.8%
+NZ$3.1m		36.3%PE26.2x
BLT BLIS TechnologiesNZ$0.0166.7%
+NZ$1.3m		6.7%PE29.6x

Latest News

AFT
NZ$3.68
AFT Pharmaceuticals
7D
0.8%
1Y
36.3%
BLT
NZ$0.016
BLIS Technologies
7D
6.7%
1Y
6.7%
RUA
NZ$0.029
Rua Bioscience
7D
-3.3%
1Y
7.4%